Cargando…
Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
Icariin is a biologically active substance in Epimedii herba that is used for the treatment of neurologic disorders. However, a comprehensive analysis of the molecular mechanisms of icariin is lacking. In this review, we present a brief history of the use of icariin for medicinal purposes; describe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384151/ https://www.ncbi.nlm.nih.gov/pubmed/34447243 http://dx.doi.org/10.2147/DDDT.S310686 |
_version_ | 1783741857868546048 |
---|---|
author | Wang, Shuangqiu Ma, Jiarui Zeng, Yanqi Zhou, Guowei Wang, Yuxuan Zhou, Wenjuan Sun, Xiaohe Wu, Minghua |
author_facet | Wang, Shuangqiu Ma, Jiarui Zeng, Yanqi Zhou, Guowei Wang, Yuxuan Zhou, Wenjuan Sun, Xiaohe Wu, Minghua |
author_sort | Wang, Shuangqiu |
collection | PubMed |
description | Icariin is a biologically active substance in Epimedii herba that is used for the treatment of neurologic disorders. However, a comprehensive analysis of the molecular mechanisms of icariin is lacking. In this review, we present a brief history of the use of icariin for medicinal purposes; describe the active chemical components of Epimedii herba; and examine the evidence from experimental studies that have uncovered molecular targets of icariin in different diseases. We also constructed a protein–protein interaction network and carried out Gene Ontology and Kyoto Encyclopedia of Genes and Genomes functional enrichment analyses to predict the therapeutic actions of icariin in nervous system diseases including Alzheimer disease, Parkinson disease, ischemic stroke, depressive disorder, multiple sclerosis, glioblastoma, and hereditary spastic paraplegias. The results of our analyses can guide future studies on the application of icariin to the treatment of neurologic disorders. |
format | Online Article Text |
id | pubmed-8384151 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-83841512021-08-25 Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review Wang, Shuangqiu Ma, Jiarui Zeng, Yanqi Zhou, Guowei Wang, Yuxuan Zhou, Wenjuan Sun, Xiaohe Wu, Minghua Drug Des Devel Ther Review Icariin is a biologically active substance in Epimedii herba that is used for the treatment of neurologic disorders. However, a comprehensive analysis of the molecular mechanisms of icariin is lacking. In this review, we present a brief history of the use of icariin for medicinal purposes; describe the active chemical components of Epimedii herba; and examine the evidence from experimental studies that have uncovered molecular targets of icariin in different diseases. We also constructed a protein–protein interaction network and carried out Gene Ontology and Kyoto Encyclopedia of Genes and Genomes functional enrichment analyses to predict the therapeutic actions of icariin in nervous system diseases including Alzheimer disease, Parkinson disease, ischemic stroke, depressive disorder, multiple sclerosis, glioblastoma, and hereditary spastic paraplegias. The results of our analyses can guide future studies on the application of icariin to the treatment of neurologic disorders. Dove 2021-08-20 /pmc/articles/PMC8384151/ /pubmed/34447243 http://dx.doi.org/10.2147/DDDT.S310686 Text en © 2021 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Wang, Shuangqiu Ma, Jiarui Zeng, Yanqi Zhou, Guowei Wang, Yuxuan Zhou, Wenjuan Sun, Xiaohe Wu, Minghua Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review |
title | Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review |
title_full | Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review |
title_fullStr | Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review |
title_full_unstemmed | Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review |
title_short | Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review |
title_sort | icariin, an up-and-coming bioactive compound against neurological diseases: network pharmacology-based study and literature review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384151/ https://www.ncbi.nlm.nih.gov/pubmed/34447243 http://dx.doi.org/10.2147/DDDT.S310686 |
work_keys_str_mv | AT wangshuangqiu icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview AT majiarui icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview AT zengyanqi icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview AT zhouguowei icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview AT wangyuxuan icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview AT zhouwenjuan icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview AT sunxiaohe icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview AT wuminghua icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview |